Ruxolitinib Switch-Maintenance Prophylaxis of GVHD
Randomized Pilot Study of Ruxolitinib for Switch-Maintenance Prophylaxis of Graft-versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation After Intermediate-Dose Post-Transplant Cyclophosphamide (Rux Switch-Maintenance in Intermediate PTCY: RuSMa-PTCY) in Comparison to Full-Dose PTCY
Near Add Your Location
Sorting 5 by
MDS Center of Excellence
A Center of Excellence as recognized by the MDS Foundation, is a hospital that has demonstrated its commitment to MDS research. This is accomplished by conducting specialized genetic testing, offering ongoing clinical trials for MDS patients, and actively participating in peer-reviewed MDS research.
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Commack
Commack, NY
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale, NY
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Bergen
Montvale, NJ
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Westchester
West Harrison, NY
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.